Journal of Renal Nutrition
Volume 11, Issue 1 , Pages 37-45 , January 2001

Are Lipid Values and BMI Related to Hospitalizations in the Hemodialysis Population?

  • M. Eileen Baugh, PhD

      Affiliations

    • Dialysis Associates, Fort Worth, TX.
    • ,
  • Michael L. Stoltz, MD

      Affiliations

    • Dialysis Associates, Fort Worth, TX.
    • ,
  • Anne D. VanBeber, PhD, RD, LD

      Affiliations

    • Associate Professor and Chair, Texas Christian University, Department of Nutrition and Dietetics, Fort Worth, TX.
    • Corresponding Author InformationAddress reprint requests to Anne D. VanBeber, PhD, RD, LD, Associate Professor and Chair, Texas Christian University, Department of Nutrition and Dietetics, PO Box 298600, Fort Worth, TX 76129.
    • ,
  • Mary Anne Gorman, PhD, RD, LD, FADA

      Affiliations

    • Professor, Texas Christian University, Department of Nutrition and Dietetics, Fort Worth, TX.

References 

  1. Parfrey PS. Pathogenesis of cardiac disease in dialysis patients. Semin Dial. 1999;12:62–68
  2. Becker BN, Himmelfarb J, Henrich WL, et al. Reassessing the cardiac risk profile in chronic hemodialysis patients: A hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors. J Am Soc Nephrol. 1997;8:475–486
  3. Bloembergen WE. Cardiac disease in chronic uremia: Epidemiology. Adv Ken Replace Ther. 1997;4:185–193
  4. Parfrey PS, Foley RN. Risk factors for cardiac dysfunction in dialysis patients: Implications for patient care. Semin Dial. 1997;10:137–141
  5. Sarnak MJ, Levey AS. Epidemiology of cardiac disease in dialysis patients. Semin Dial. 1999;12:69–76
  6. Appel BG. How should the lipid abnormalities of dialysis patients be treated?. Semin Dial. 1995;1:15–16
  7. Meyer KB, Levey AS. Controlling the epidemic of cardiovascular disease in chronic renal disease: Report from the National Kidney Foundation Task Force on Cardiovascular Disease. J Am Soc Nephrol. 1998;9:S31–S42
  8. Prichard S. Dyslipidemia as a risk factor for cardiac disease in dialysis patients. Semin Dial. 1999;12:87–90
  9. Nishizawa Y, Shoji T, Kawagishi T, et al. Atherosclerosis in uremia: Possible roles of hyperparathyroidism and intermediate density lipoprotein accumulation. Kidney Int. 1997;52(suppl 62):S90–S92
  10. Attman P-O, Alaupovic P. Lipid abnormalities in chronic renal insufficiency. Kidney Int. 1991;39(suppl 31):S16–S23
  11. Wanner C, Zimmerman J, Quaschning T, et al. Inflammation, dyslipidemia and vascular risk factors in hemodialysis patients. Kidney Int. 1997;52(suppl 62):S53–S55
  12. Avram MM, Goldwasser P, Burrer DE, et al. The uremic dyslipidemia: A cross-sectional and longitudinal study. Am J Kidney Dis. 1992;20:324–335
  13. Elisaf M, Mikhailidis DP, Siamopoulos KC. Dyslipidemia in patients with renal diseases. J Drug Dev Clin Pract. 1996;7:331–348
  14. Avram MM, Fein PA, Antignani A, et al. Cholesterol and lipid disturbances in renal disease: The natural history of uremic dyslipidemia and the impact of hemodialysis and continuous ambulatory peritoneal dialysis. Am J Med. 1989;87:5N–55N
  15. Elisaf MS, Dardamanis MA, Papagalanis ND, et al. Lipid abnormalities in chronic uremic patients. Scand J Urol Nephrol. 1993;27:101–108
  16. Elisaf M, Bairaktari H, Tzallas C, et al. Lipid parameters including Lp(a) in hemodialysis patients. Ren Fail. 1994;16:501–509
  17. Attman PO, Alaupovic P. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia: Relation to renal function and dialysis. Nephron. 1991;57:401–410
  18. Fuh MMT, Lee CM, Jeng CY, et al. Effect of chronic renal failure on high-density lipoprotein kinetics. Kidney Int. 1990;37:1295–1300
  19. Shoji T, Nishizawa Y, Nishitani H, et al. Impaired metabolism of high-density lipoprotein in uremic patients. Kidney Int. 1992;41:1653–1661
  20. Nicoll A, Lewis B. Evaluation of the roles of lipoprotein lipase and hepatic triglyceride lipase in lipoprotein metabolism: In vivo and in vitro studies in man. Eur J Clin Invest. 1980;10:487–495
  21. Eisenberg S. High-density lipoprotein metabolism. J Lipid Res. 1984;25:1017–1083
  22.  Tietz NW editors. Textbook of Clinical Chemistry. Philadelphia, PA: Saunders; 1986;
  23. Elisaf MS, Bairaktari HT, Tziallas CS, et al. Atherogenic lipid and lipoprotein parameters in hemodialysis patients. Nephrol Dial Transplant. 1995;24:642–650
  24. Lamarache B, Tchernof A, Mauriege P, et al. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA. 1998;279:1955–1961
  25. Westerveld HT, Roeters van Lennep JE, Roeters van Lennep HW, et al. Apolipoprotein B and coronary artery disease in women. A cross-sectional study in women undergoing their first coronary angiography. Arterioscler Thromb Vasc Biol. 1998;18:1101–1107
  26. Nikolic J, Brown R, Campbell M, et al. High body mass index (BMI) does not adversely affect cardiovascular (CV) and all-cause mortality in hemodialysis patients. J Am Soc Nephrol. 1997;8:205A;(abstr)
  27. Kopple JD, Lew NL, Zhu X, et al. Body weight predicts mortality in maintenance hemodialysis (MHD) patients. J Am Soc Nephrol. 1997;8:198A;(abstr)
  28. US Renal Data System. Excerpts from the USRDS 1997 annual data report. V. Patient mortality and survival. Am J Kidney Dis. 1997;30(suppl 1):S86–S106
  29. Lazarus JM. Nutrition in hemodialysis patients. Am J Kidney Dis. 1993;21:99–105
  30. Avram MM, Mittman N, Bonomini L, et al. Markers for survival in dialysis: A seven-year prospective study. Am J Kidney Dis. 1995;26:209–219
  31. Kopple JD, Hakim RM, Held PJ, et al. Recommendations for reducing the high morbidity and mortality of United States maintenance dialysis patients: The National Kidney Foundation. Am J Kidney Dis. 1994;24:968–973
  32. Leavey SF, Strawderman RL, Jones CA, et al. Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis. 1998;31:997–1006
  33. Fleischmann E, Teal N, Dudley J, et al. Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int. 1999;55:1560–1567
  34. Foley RN, Parfrey PS, Sarnak MJ. Cardiovascular disease in chronic renal disease: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(suppl 3):S112–S119
  35. Kasiske BL. Hyperlipidemia in patients with chronic renal disease. Am J Kidney Dis. 1998;32(suppl 3):S142–S156

 Work conducted at Dialysis Associates, Fort Worth, TX.

PII: S1051-2276(01)10884-8

Journal of Renal Nutrition
Volume 11, Issue 1 , Pages 37-45 , January 2001

Article Tools